Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Zhao, Xiaohong ^a   Yang, Li ^a   Hu, Jianguo ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

drug resistance; gastric carcinoma; miR 27a; porliferation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA ACTIN; CISPLATIN; CYCLIN D1; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MICRORNA; MICRORNA 27A; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG; VINCRISTINE; MIRN27 MICRORNA, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; STOMACH CANCER; WESTERN BLOTTING; ANIMAL; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; NUDE MOUSE; PATHOPHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICRORNAS; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79955847973     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-55     Document Type: Article

References (11)

1. MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs. A Bhardwaj S Singh AP Singh, Mol Cell Pharmacol 2010 2 5 213 219 21289871
2. Long noncoding RNA as a regulator for transcription. R Kurokawa, Prog Mol Subcell Biol 2011 51 29 41 10.1007/978-3-642-16502-3-2 21287132
3. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. H Zhang M Li Y Han L Hong T Gong L Sun X Zheng, Dig Dis Sci 2010 55 9 2545 51 10.1007/s10620-009-1051-6 19960259
4. MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor {beta}1 in neonatal rat ventricular myocytes. H Nishi K Ono T Horie K Nagao M Kinoshita Y Kuwabara S Watanabe T Kimura, Mol Cell Biol 2011 31 4 744 55 10.1128/MCB.00581-10 21149577
5. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Y Ma S Yu W Zhao Z Lu J Chen, Cancer Lett 2010 298 2 150 8 10.1016/j.canlet.2010.06.012 20638779
6. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. DL Allen AS Loh, Am J Physiol Cell Physiol 2011 300 1 124 37 10.1152/ajpcell.00142.2010
7. Hsa-mir-27 genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Q Sun H Gu Y Zeng Y Xia Y Wang Y Jing L Yang B Wang, Cancer Sci 2010 101 10 2241 7 10.1111/j.1349-7006. 2010.01667.x 20666778
8. Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells. ZM Li S Hu L Xiao J Wang J Cai LL Yu ZH Wang, Zhonghua Fu Chan Ke Za Zhi 2010 45 5 372 5 20646448
9. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Z Li S Hu J Wang J Cai L Xiao L Yu Z Wang, Gynecol Oncol 2010 119 1 125 30 10.1016/j.ygyno.2010.06.004 20624637
10. MicroRNA-27a indirectly regulates estrogen receptor {alpha} expression and hormone responsiveness in MCF-7 breast cancer cells. X Li SU Mertens-Talcott S Zhang K Kim J Ball S Safe, Endocrinology 2010 151 6 2462 73 10.1210/en.2009-1150 20382698
11. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. SY Kim AY Kim HW Lee YH Son YS Lee JB Kim, Biochem Biophys Res Commun 2010 392 3 323 8 10.1016/j.bbrc.2010.01.012 20060380